Literature DB >> 15040832

Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways.

Takeshi Sakata1, Yongmei Wang, Bernard P Halloran, Hashem Z Elalieh, Jay Cao, Daniel D Bikle.   

Abstract

UNLABELLED: We showed that unloading markedly diminished the effects of IGF-I to activate its signaling pathways, and the disintegrin echistatin showed a similar block in osteoprogenitor cells. Furthermore, unloading decreased alphaVbeta3 integrin expression. These results show that skeletal unloading induces resistance to IGF-I by inhibiting activation of the IGF-I signaling pathways at least in part through downregulation of integrin signaling.
INTRODUCTION: We have previously reported that skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) with respect to bone formation. However, the underlying mechanism remains unclear. The aim of this study was to clarify how skeletal unloading induces resistance to the effects of IGF-I administration in vivo and in vitro with respect to bone formation.
MATERIALS AND METHODS: We first determined the response of bone to IGF-I administration in vivo during skeletal unloading. We then evaluated the response of osteoprogenitor cells isolated from unloaded bones to IGF-I treatment in vitro with respect to activation of the IGF-I signaling pathways. Finally we examined the potential role of integrins in mediating the responsiveness of osteoprogenitor cells to IGF-I.
RESULTS: IGF-I administration in vivo significantly increased proliferation of osteoblasts. Unloading markedly decreased proliferation and blocked the ability of IGF-I to increase proliferation. On a cellular level, IGF-I treatment in vitro stimulated the activation of its receptor, Ras, ERK1/2 (p44/42 MAPK), and Akt in cultured osteoprogenitor cells from normally loaded bones, but these effects were markedly diminished in cells from unloaded bones. These results were not caused by altered phosphatase activity or changes in receptor binding to IGF-I. Inhibition of the Ras/MAPK pathway was more impacted by unloading than that of Akt. The disintegrin echistatin (an antagonist of the alphaVbeta3 integrin) blocked the ability of IGF-I to stimulate its receptor phosphorylation and osteoblast proliferation, similar to that seen in cells from unloaded bone. Furthermore, unloading significantly decreased the mRNA levels both of alphaV and beta3 integrin subunits in osteoprogenitor cells.
CONCLUSION: These results indicate that skeletal unloading induces resistance to IGF-I by inhibiting the activation of IGF-I signaling pathways, at least in part, through downregulation of integrin signaling, resulting in decreased proliferation of osteoblasts and their precursors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15040832     DOI: 10.1359/JBMR.0301241

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  38 in total

1.  Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling.

Authors:  Roger K Long; Shigeki Nishida; Takuo Kubota; Yongmei Wang; Takeshi Sakata; Hashem Z Elalieh; Bernard P Halloran; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 2.  Bone cell-matrix protein interactions.

Authors:  P J Marie
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

Review 3.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

Review 5.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

Review 6.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

Review 7.  Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.

Authors:  Yongyong Yan; Liping Wang; Linhu Ge; Janak L Pathak
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

8.  Insulin Resistance Negatively Influences the Muscle-Dependent IGF-1-Bone Mass Relationship in Premenarcheal Girls.

Authors:  J M Kindler; N K Pollock; E M Laing; N T Jenkins; A Oshri; C Isales; M Hamrick; R D Lewis
Journal:  J Clin Endocrinol Metab       Date:  2015-11-17       Impact factor: 5.958

9.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

Authors:  V E DeMambro; D R Clemmons; L G Horton; M L Bouxsein; T L Wood; W G Beamer; E Canalis; C J Rosen
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

10.  Effects of alcohol on skeletal response to growth hormone in hypophysectomized rats.

Authors:  Russell T Turner; Clifford J Rosen; Urszula T Iwaniec
Journal:  Bone       Date:  2009-10-30       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.